Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP435041.RAZYNhF8vqVdw2rzDx3ML9kTcUo-wt_3fQ2__pdJMNd2k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP435041.RAZYNhF8vqVdw2rzDx3ML9kTcUo-wt_3fQ2__pdJMNd2k130_assertion type Assertion NP435041.RAZYNhF8vqVdw2rzDx3ML9kTcUo-wt_3fQ2__pdJMNd2k130_head.
- NP435041.RAZYNhF8vqVdw2rzDx3ML9kTcUo-wt_3fQ2__pdJMNd2k130_assertion description "[We used human osteosarcoma cells (MG-63) and measured hVDR and GR mRNA levels after androgen, estrogen, glucocorticoid, progesterone, thyroid hormone, vitamin A and vitamin D treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435041.RAZYNhF8vqVdw2rzDx3ML9kTcUo-wt_3fQ2__pdJMNd2k130_provenance.
- NP435041.RAZYNhF8vqVdw2rzDx3ML9kTcUo-wt_3fQ2__pdJMNd2k130_assertion evidence source_evidence_literature NP435041.RAZYNhF8vqVdw2rzDx3ML9kTcUo-wt_3fQ2__pdJMNd2k130_provenance.
- NP435041.RAZYNhF8vqVdw2rzDx3ML9kTcUo-wt_3fQ2__pdJMNd2k130_assertion SIO_000772 1846564 NP435041.RAZYNhF8vqVdw2rzDx3ML9kTcUo-wt_3fQ2__pdJMNd2k130_provenance.
- NP435041.RAZYNhF8vqVdw2rzDx3ML9kTcUo-wt_3fQ2__pdJMNd2k130_assertion wasDerivedFrom befree-20150227 NP435041.RAZYNhF8vqVdw2rzDx3ML9kTcUo-wt_3fQ2__pdJMNd2k130_provenance.
- NP435041.RAZYNhF8vqVdw2rzDx3ML9kTcUo-wt_3fQ2__pdJMNd2k130_assertion wasGeneratedBy ECO_0000203 NP435041.RAZYNhF8vqVdw2rzDx3ML9kTcUo-wt_3fQ2__pdJMNd2k130_provenance.